Antibiotic susceptibility of mammalian mitochondrial translation
10.1016/j.febslet.2005.09.103 · doi-reference
Bacterial translation elongation factor EF-Tu interacts and colocalizes with actin-like MreB protein
10.1073/pnas.0911979107 · doi-reference
Extraintestinal pathogenic Escherichia coli utilizes surface-located elongation factor G to acquire iron from holo-transferrin
10.1128/spectrum.01662-21 · doi-reference
Extraintestinal pathogenic Escherichia coli utilizes the surface-expressed elongation factor Tu to bind and acquire iron from holo-transferrin
10.1080/21505594.2022.2066274 · doi-reference
Mycobacterium tuberculosis acquires iron by cell-surface sequestration and internalization of human holo-transferrin
10.1038/ncomms5730 · doi-reference
Association of Acinetobacter baumannii EF‐Tu with cell surface, outer membrane vesicles, and fibronectin
10.1100/2012/128705 · doi-reference
Elongation factor Tu and E1 beta subunit of pyruvate dehydrogenase complex act as fibronectin binding proteins in M. pneumoniae
10.1046/j.1365-2958.2002.03207.x · doi-reference
Immune evasion of the human pathogen P. aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein
10.4049/jimmunol.179.5.2979 · doi-reference
Identification of novel bacterial plasminogen‐binding proteins in the human pathogen Mycobacterium tuberculosis
10.1002/pmic.200600876 · doi-reference
Computer-aided drug design approaches for the identification of potent inhibitors targeting elongation factor G of Mycobacterium tuberculosis
10.1016/j.jmgm.2025.108954 · doi-reference
Determinants of antibacterial spectrum and resistance potential of the elongation factor G inhibitor argyrin B in key Gram-negative pathogens
10.1128/aac.02400-16 · doi-reference
The cyclic octapeptide antibiotic argyrin B inhibits translation by trapping EF-G on the ribosome during translocation
10.1073/pnas.2114214119 · doi-reference
Identification of elongation factor G as the conserved cellular target of argyrin B
10.1371/journal.pone.0042657 · doi-reference
Argyrins, immunosuppressive cyclic peptides from myxobacteria. Part 1. production, isolation, physico‐chemical and biological properties
10.1002/chin.200248192 · doi-reference
Susceptibility of mycobacteria to fusidic acid
10.1007/bf01968066 · doi-reference
Antimicrobial and antibiofilm effects of bithionol against Mycobacterium abscessus
10.3390/antibiotics13060529 · doi-reference
A central interdomain protein joint in elongation factor G regulates antibiotic sensitivity, GTP hydrolysis, and ribosome translocation
10.1074/jbc.m110.214056 · doi-reference
The postantibiotic effect of fusidic acid against gram-positive bacteria
10.1093/jac/40.3.433 · doi-reference
Fusidic acid targets elongation factor G in several stages of translocation on the bacterial ribosome
10.1074/jbc.m114.611608 · doi-reference
Fusidic acid in vitro activity
10.1016/s0924-8579(98)00073-9 · doi-reference
Fucidin: a new orally active antibiotic
10.1016/s0140-6736(62)91968-2 · doi-reference
Fusidic acid: a new antibiotic
10.1038/193987a0 · doi-reference
Crystal structure of Mycobacterium tuberculosis elongation factor G1
10.3389/fmolb.2021.667638 · doi-reference
Ribosome rescue inhibitors kill actively growing and nonreplicating persister Mycobacterium tuberculosis cells
10.1021/acsinfecdis.7b00028 · doi-reference
trans-translation inhibitors that kill Mycobacterium tuberculosis and pathogenic non-tuberculous mycobacteria also disrupt metal homeostasis
10.1099/mic.0.001716 · doi-reference
Tetrazole-based trans-translation inhibitors kill bacillus anthracis spores to protect host cells
10.1128/aac.01199-17 · doi-reference
Inhibitors of ribosome rescue arrest growth of Francisella tularensis at all stages of intracellular replication
10.1128/aac.03089-15 · doi-reference
